Study of XEN63 gel stent for glaucoma patients
Part of Eyes & vision clinical trials.
This trial tests a new gel stent (XEN63) to lower eye pressure in adults with glaucoma. It compares two ways of putting the stent in the eye, and may help people who have not had success with other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with glaucoma in the study eye.
- Your eye pressure is not controlled with at least 4 types of eye drops (or fewer if some caused side effects or are not safe for you).
- You have had at least one glaucoma surgery in the past that required making a cut in the eye.
- If you have not had prior glaucoma surgery, only 10 people in each group will be allowed, and your eye pressure must still be uncontrolled with medication alone.
- You cannot have certain types of glaucoma like narrow-angle (unless surgically opened), or secondary glaucoma from other eye conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two glaucoma operations to see which works better at lowering eye pressure and keeping the eye stable. It’s for adults with open-angle glaucoma who are eligible for either surgery and can attend follow-up visits.
This trial is testing a small device called the PRESERFLO MicroShunt to lower eye pressure in people with open-angle glaucoma. It may be an option if your eye pressure stays high even with maximum eye drops.
This trial tests a surgical system for people with mild to moderate open-angle glaucoma. It may be an option if you are having cataract surgery or have already had it, and your eye pressure is not well controlled with medications.
This study enrolls people who have cataracts and primary open-angle glaucoma that is being treated with eye drops. It will look at how well the Hydrus microstent works after approval, especially for lowering eye pressure safely.
This study tests a new gel implant (XEN63) to lower eye pressure in adults with open-angle glaucoma. It may be an option if your eye pressure remains high despite using eye drops, or if you can't tolerate the drops.
This trial compares two different tiny drainage devices (a gel stent and a microshunt) for lowering eye pressure in people with certain types of glaucoma that are not well controlled with medications. The goal is to see which device works better and is safer.
Hear when a new Primary Open Angle Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.